Debut Plus

58.5

+0.65 +1.12%

As of 09 Sept 2026 · delayed

NSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-09-10

Vilin Bio Med Limited (VILINBIO)

Volume: 40,000Avg Vol 1W: 69,600Avg Vol 1M: 31,80052W Range:18.9560.95
Key Ratios
Checked 8h ago
Market Cap₹88 Cr
Current Price₹58.5
Previous Close₹57.85
High / Low (52w)₹60.95 / ₹18.95
Volume40,000
Avg Vol (1W)69,600
Avg Vol (1M)31,800
Stock P/E45.91
Book Value₹18.6
Dividend Yield0%
ROE6.8%
ROA390.3%
Revenue (TTM)₹15 Cr
Revenue Growth
Profit Margin8.4%
Total Debt
Shares Outstanding2 Cr
Face Value
EPS (TTM)₹1.26
P/B3.11
Debt / Equity0.2
50 DMA₹44.48
200 DMA₹35.54
Day change+1.12%
SurveillanceLT-ASM · ASM 1
Price Chart
58.5 149.47% · 1Y
60191.2L
2025-09-10
2026-09-09

20-day avg volume: 32K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 44% YoY.
  • Net profit is growing year over year.
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹17 Cr₹12 Cr₹11 Cr₹12 Cr₹16 Cr₹15 Cr
EBITDA₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr
EPS0.20.150.11.250.120.16
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹14 Cr₹14 Cr₹14 Cr₹18 Cr₹32 Cr₹28 Cr
Total Liabilities₹7 Cr₹7 Cr₹6 Cr₹7 Cr₹10 Cr₹5 Cr
Equity₹7 Cr₹7 Cr₹7 Cr₹11 Cr₹23 Cr₹23 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹-1 Cr₹0 Cr₹-1 Cr₹-7 Cr₹1 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹-1 Cr
Financing₹1 Cr₹0 Cr₹2 Cr₹9 Cr₹-5 Cr
Free Cash Flow₹-1 Cr₹0 Cr₹-1 Cr₹-7 Cr₹1 Cr
Shareholding
Promoter 56.65% Institutions 0% Public 43.35%
Efficiency & Working Capital
ROCE10.2%
Interest Coverage1.4
Dividend Payout
Debtor Days155 d
Inventory Days109 d
Payable Days34 d
Cash Conversion Cycle230 d
Working Capital Days264 d
Shareholding Details

As of 2026-06-30

Promoter56.6%
FII0%
DII0%
Institutions0%
Public43.4%
Promoter Pledge0%
No. of Shareholders382
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026May 2026May 2026Jun 2026
Promoters90.5%64.5%64.5%64.1%63.9%63.9%63.9%63.7%59.6%56.6%56.6%56.6%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public9.5%35.5%35.5%35.9%36.1%36.1%36.1%36.3%40.4%43.4%43.4%43.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders21659585581551492476462397400400382
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Sharaz ShaikShareholding of Promoter and Promoter Group12%18,31,979
Shankar Reddy KatireddyShareholding of Promoter and Promoter Group11.7%17,80,520
Pravallika VennaShareholding of Promoter and Promoter Group8.8%13,35,400
Allu Ramakrishna ReddyShareholding of Promoter and Promoter Group7.3%11,12,830
Julakanti Naga Avinash ReddyShareholding of Promoter and Promoter Group5.8%8,90,260
Enspire Institute Of Professional Studies LlpPublic Shareholding4.4%6,70,000
Karunakar Reddy KundoorShareholding of Promoter and Promoter Group4.4%6,67,700
Amn Ventures LlpPublic Shareholding4.1%6,30,000
Percy Homi ItaliaPublic Shareholding3.9%5,98,000
Mohan Rao AdhiShareholding of Promoter and Promoter Group3.3%5,05,130
Jwala Veeravenkata Panduranga PraneethShareholding of Promoter and Promoter Group2.9%4,45,130
KrishnaPublic Shareholding2.9%4,36,000
Srinivasa Reddy DevireddyPublic Shareholding1.9%2,85,425
Bosco Armando MenezesPublic Shareholding1.1%1,64,000
Chenugonipally Maheshwar ReddyPublic Shareholding1.1%1,64,000
Glaston Mario MenezesPublic Shareholding1.1%1,64,000
Tanmayee Reddy SamaShareholding of Promoter and Promoter Group0.1%21,250
Ramiza ShaikShareholding of Promoter and Promoter Group0.1%20,000
Anuj BajpaiShareholding of Promoter and Promoter Group0.1%15,000
Sneh BajpaiShareholding of Promoter and Promoter Group0.1%9,375
Shaik SarafShareholding of Promoter and Promoter Group0%4,000
Board of Directors
NameDesignationYear
MADHUSUDHAN YADAMAKANTI REDDYManaging Director2025
PRASANNA LAKSHMI VENNAWhole-time Director2025
S Viswa PrasadWhole-time Director2025
SASIKANTH PARITALAIndependent Non Exe. Director2025
VEERAIAH CHOWDARY KOLLAIndependent Non Exe. Director2025
GIRISH GIRISH MUKTEVIIndependent Non Exe. Director2025
Dhruv Vishwanath Todi.Company Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing and Selling of Pharma₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10151414
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500001010
202500001010
2025000000
Company Information
Incorporated2005
AuditorPPKG & Co
Investor Email[email protected]
🌐 www.vilinbiomed.co.in

📍 Sy #115/GF/J Hanumanji Colony, Brig Sayeed Rd Bowempally, Secunderabad, Telangana, 500003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search